Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Mar;3(1):25-30.
doi: 10.1093/ecam/nek022. Epub 2006 Feb 7.

Regulatory T cells, a potent immunoregulatory target for CAM researchers: the ultimate antagonist (I)

Affiliations

Regulatory T cells, a potent immunoregulatory target for CAM researchers: the ultimate antagonist (I)

Aristo Vojdani et al. Evid Based Complement Alternat Med. 2006 Mar.

Abstract

Over the past decade, great interest has been given to regulatory T (T(reg)) cells. A vast body of evidence has shown the existence and highlighted the importance of T(reg) cells in the active suppression of immune system responses. This form of immunoregulation is the dominant means utilized by the immune system to reach a harmony between reciprocal response processes in order to ensure adequate host defense with minimal host detriment. Therapeutically targeting T(reg) cells is a direct and powerful means to manipulate the immune system to achieve beneficial effects on various disease pathologies, including allergy, autoimmunity and cancer, as well as the facilitation of organ transplantation. This powerful target for immunoregulation is of much concern to practitioners and researchers of complementary and alternative medicine because it allows a great deal of control and certainty in dealing with the prevalence of debilitating immune system-related disorders for which there has been little remedy outside of Western Medicine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The mediators of immune system responses.

References

    1. Bellavite P, Conforti A, Piasere V, Ortolani R. Immunology and homeopathy. 1. Historical background. Evid Based Complement Alternat Med. 2005;2:441–52. - PMC - PubMed
    1. Lindequist U, Niedermeyer THJ, Jülich W. The Pharmacological potential of mushrooms. Evid Based Complement Alternat Med. 2005;2:285–99. - PMC - PubMed
    1. Inagaki N, Shibata T, Itoh T, Suzuki T, Tanaka H, Nakamura T, et al. Inhibition of IgE-dependent mouse triphasic cutaneous reaction by a boiling water fraction separated from mycelium of Phellinus linteus. Evid Based Complement Alternat Med. 2005;2:369–74. - PMC - PubMed
    1. Naser B, Bodinet C, Tegtmeier M, Lindequist U. Thuja occidentalis (Arbor vitae): a review of its pharmaceutical, pharmacological and clinical properties. Evid Based Complement Alternat Med. 2005;2:69–78. - PMC - PubMed
    1. Padmavathi B, Rath PC, Rao AR, Singh RP. Roots of Withania somnifera inhibit forestomach and skin carcinogenesis in mice. Evid Based Complement Alternat Med. 2005;2:99–105. - PMC - PubMed

LinkOut - more resources